578 related articles for article (PubMed ID: 17912186)
41. Extraintestinal manifestations in Crohn's disease and ulcerative colitis: results from a prospective, population-based European inception cohort.
Isene R; Bernklev T; Høie O; Munkholm P; Tsianos E; Stockbrügger R; Odes S; Palm Ø; Småstuen M; Moum B;
Scand J Gastroenterol; 2015 Mar; 50(3):300-5. PubMed ID: 25535653
[TBL] [Abstract][Full Text] [Related]
42. [Hepatobiliary complications of idiopathic intestinal inflammations].
Lukás M
Cas Lek Cesk; 1997 Feb; 136(4):106-10. PubMed ID: 9221179
[TBL] [Abstract][Full Text] [Related]
43. [Extra-intestinal Manifestations of chronic inflammatory Bowel diseases].
Pierer M; Krause C; Häntzschel H
Z Gastroenterol; 2002 Apr; 40 Suppl 1():S92-S4. PubMed ID: 11930300
[TBL] [Abstract][Full Text] [Related]
44. Extraintestinal manifestations of inflammatory bowel disease and the influence of smoking.
Roberts H; Rai SN; Pan J; Rao JM; Keskey RC; Kanaan Z; Short EP; Mottern E; Galandiuk S
Digestion; 2014; 90(2):122-9. PubMed ID: 25277851
[TBL] [Abstract][Full Text] [Related]
45. Inflammatory bowel disease: complications and extraintestinal manifestations.
Scherer JR
Drugs Today (Barc); 2009 Mar; 45(3):227-41. PubMed ID: 19436844
[TBL] [Abstract][Full Text] [Related]
46. Treatment of immune-mediated extraintestinal manifestations of inflammatory bowel disease with infliximab.
Barrie A; Plevy S
Gastroenterol Clin North Am; 2006 Dec; 35(4):883-93. PubMed ID: 17129819
[TBL] [Abstract][Full Text] [Related]
47. Oral manifestations of inflammatory bowel disease: a review based on the observation of six cases.
Lourenço SV; Hussein TP; Bologna SB; Sipahi AM; Nico MM
J Eur Acad Dermatol Venereol; 2010 Feb; 24(2):204-7. PubMed ID: 19552719
[TBL] [Abstract][Full Text] [Related]
48. Relationship of extraintestinal involvements in inflammatory bowel disease: new insights into autoimmune pathogenesis.
Das KM
Dig Dis Sci; 1999 Jan; 44(1):1-13. PubMed ID: 9952216
[TBL] [Abstract][Full Text] [Related]
49. Autoimmune diseases of the liver and biliary tract and overlap syndromes in childhood.
Maggiore G; Riva S; Sciveres M
Minerva Gastroenterol Dietol; 2009 Mar; 55(1):53-70. PubMed ID: 19212308
[TBL] [Abstract][Full Text] [Related]
50. Biologics for extraintestinal manifestations of IBD.
Vavricka SR; Scharl M; Gubler M; Rogler G
Curr Drug Targets; 2014; 15(11):1064-73. PubMed ID: 25198785
[TBL] [Abstract][Full Text] [Related]
51. Extra-intestinal manifestations of Crohn's disease.
Ephgrave K
Surg Clin North Am; 2007 Jun; 87(3):673-80. PubMed ID: 17560419
[TBL] [Abstract][Full Text] [Related]
52. Association of extraintestinal manifestations of inflammatory bowel disease in a province of western Hungary with disease phenotype: results of a 25-year follow-up study.
Lakatos L; Pandur T; David G; Balogh Z; Kuronya P; Tollas A; Lakatos PL
World J Gastroenterol; 2003 Oct; 9(10):2300-7. PubMed ID: 14562397
[TBL] [Abstract][Full Text] [Related]
53. Beyond the Bowel: Extraintestinal Manifestations of Inflammatory Bowel Disease.
Olpin JD; Sjoberg BP; Stilwill SE; Jensen LE; Rezvani M; Shaaban AM
Radiographics; 2017; 37(4):1135-1160. PubMed ID: 28548906
[TBL] [Abstract][Full Text] [Related]
54. Prevalence and Characteristics of Extra-intestinal Manifestations in a Large Cohort of Greek Patients with Inflammatory Bowel Disease.
Karmiris K; Avgerinos A; Tavernaraki A; Zeglinas C; Karatzas P; Koukouratos T; Oikonomou KA; Kostas A; Zampeli E; Papadopoulos V; Theodoropoulou A; Viazis N; Polymeros D; Michopoulos S; Bamias G; Kapsoritakis A; Karamanolis DG; Mantzaris GJ; Tzathas C; Koutroubakis IE
J Crohns Colitis; 2016 Apr; 10(4):429-36. PubMed ID: 26721936
[TBL] [Abstract][Full Text] [Related]
55. Extraintestinal Manifestations of Inflammatory Bowel Disease: Current Concepts, Treatment, and Implications for Disease Management.
Rogler G; Singh A; Kavanaugh A; Rubin DT
Gastroenterology; 2021 Oct; 161(4):1118-1132. PubMed ID: 34358489
[TBL] [Abstract][Full Text] [Related]
56. Skin manifestations of inflammatory bowel disease.
Timani S; Mutasim DF
Clin Dermatol; 2008; 26(3):265-73. PubMed ID: 18640523
[TBL] [Abstract][Full Text] [Related]
57. Extraintestinal and systemic manifestations of inflammatory bowel disease.
Rankin GB
Med Clin North Am; 1990 Jan; 74(1):39-50. PubMed ID: 2404180
[TBL] [Abstract][Full Text] [Related]
58. Relationship between clinical parameters and the colitis-colorectal cancer interval in a cohort of patients with colorectal cancer in inflammatory bowel disease.
Brackmann S; Andersen SN; Aamodt G; Langmark F; Clausen OP; Aadland E; Fausa O; Rydning A; Vatn MH
Scand J Gastroenterol; 2009; 44(1):46-55. PubMed ID: 18609187
[TBL] [Abstract][Full Text] [Related]
59. Chronological Order of Appearance of Extraintestinal Manifestations Relative to the Time of IBD Diagnosis in the Swiss Inflammatory Bowel Disease Cohort.
Vavricka SR; Rogler G; Gantenbein C; Spoerri M; Prinz Vavricka M; Navarini AA; French LE; Safroneeva E; Fournier N; Straumann A; Froehlich F; Fried M; Michetti P; Seibold F; Lakatos PL; Peyrin-Biroulet L; Schoepfer AM
Inflamm Bowel Dis; 2015 Aug; 21(8):1794-800. PubMed ID: 26020601
[TBL] [Abstract][Full Text] [Related]
60. Review article: skin complications associated with inflammatory bowel disease.
Tavarela Veloso F
Aliment Pharmacol Ther; 2004 Oct; 20 Suppl 4():50-3. PubMed ID: 15352894
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
